Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.

Pancreas - 1 Jul 2009

Däbritz Jan, Preston Roman, Hänfler Joachim, Oettle Helmut

Abstract excerpt

OBJECTIVE: We followed up the presence of Kirsten rat sarcoma (K-ras) mutations in plasma DNA and assessed its clinical value in patients with pancreatic cancer. METHODS: Plasma samples (N = 430) of 56 patients with pancreatic cancer and 13 patients with pancreatitis were analyzed by real-time polymerase chain reaction using peptide nucleic acid-mediated polymerase chain reaction clamping. RESULTS: K-ras...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-19-9 Antigen
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genes, ras

Share to Pancreatic Neoplasms

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 19295453
DOI: 10.1097/MPA.0b013e31819f6376

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.PMID 19295453Read ↗

Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.Semantic proximity Read ↗

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].Semantic proximity Read ↗

[Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].Semantic proximity Read ↗

Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.Semantic proximity Read ↗

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.Semantic proximity Read ↗

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.Semantic proximity Read ↗

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.Semantic proximity Read ↗

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity Read ↗

Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.Semantic proximity Read ↗

Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.Semantic proximity Read ↗

Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.Semantic proximity Read ↗

Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.